1-2 of 2
Petra H. M. Westveer
Close
Sort by
Journal Articles

Dose-finding study of imatinib in combination with intravenous cytarabine: feasibility in newly diagnosed patients with chronic myeloid leukemia

Clinical Trials & Observations
Wendy Deenik, Bronno van der Holt, Gregor E. G. Verhoef, Willem M. Smit, Marie J. Kersten, Hanneke C. Kluin-Nelemans, Leo F. Verdonck, Augustin Ferrant, Anton V. M. B. Schattenberg, Jeroen J. W. M. Janssen, Pieter Sonneveld, Marinus van Marwijk Kooy, Shulamit Wittebol, Roelof Willemze, Pierre W. Wijermans, Petra H. M. Westveer, H. Berna Beverloo, Peter Valk, Bob Löwenberg, Gert J. Ossenkoppele, Jan J. Cornelissen
Journal: Blood
Blood (2008) 111 (5): 2581–2588.
https://doi.org/10.1182/blood-2007-08-107482
Published: 2008
Journal Articles

The value of fludarabine in addition to ARA-C and G-CSF in the treatment of patients with high-risk myelodysplastic syndromes and AML in elderly patients

Clinical Trials & Observations
Gert J. Ossenkoppele, Wilfried J. Graveland, Pieter Sonneveld, Simon M. G. J. Daenen, Douwe H. Biesma, Leo F. Verdonck, M. Ron Schaafsma, Petra H. M. Westveer, Godefridus J. Peters, Paul Noordhuis, Petra Muus, Dominik Selleslag, Bronnie van der Holt, Michel Delforge, Bob Löwenberg, Gregor E. G. Verhoef, Dutch-Belgian Hemato-Oncology Cooperative Group (HOVON)
Journal: Blood
Blood (2004) 103 (8): 2908–2913.
https://doi.org/10.1182/blood-2003-07-2195
Published: 2004